Author

G Pagano

Observed names: G. Pagano, PAGANO G, Pagano G, Pagano, G

Observed institutions: Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, World Health Organization, Ospedale Policlinico San Martino, Ospedale D. Cotugno, Istituti di Ricovero e Cura a Carattere Scientifico, University of Genoa

ORCID: 0000-0002-8287-4558

Observed ORCID: 0000-0002-8287-4558

OpenAlex ID: A5064890767

Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment

2009 · F. Bozzano, P. Costa, et al. · International Immunology · 64

PDF

Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

2005 · for the HepaICoNA and the ICoNA Study Groups, Giorgio Antonucci, et al. · Antiviral Therapy · 31

PDF

Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy

2010 · M. Bassetti, A. Parisini, et al. · Clinical Microbiology and Infection · 30

Cutaneous cryptococcosis resembling molluscum contagiosum in a homosexual man with AIDS. Report of a case and review of the literature.

1992 · G Ghigliotti, G Carrega, et al. · Acta Dermato Venereologica · 29

Variability in the Interpretation of Transmitted Genotypic HIV-1 Drug Resistance and Prediction of Virological Outcomes of the Initial Haart by Distinct Systems

2004 · the ICoNA drug resistance study group, the ICoNA study group, et al. · Antiviral Therapy · 25

The Management of Hepatitis B Virus/HIV-1 Co-Infected Patients Starting Their First Haart Regimen. Treating Two Infections for the Price of One Drug?

2004 · the HepaI.CoNA, the ICoNA Study Group, et al. · Antiviral Therapy · 15

PDF

Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study

2001 · G. Antonucci, E. Girardi, et al. · European Respiratory Journal · 14

PDF

Is the CD4 Cell Percentage a Better Marker of Immunosuppression than the Absolute CD4 Cell Count in HIV-Infected Patients with Cirrhosis?

2007 · M. Bongiovanni, A. Gori, et al. · Clinical Infectious Diseases · 13

PDF

Evolution of HVR-1 Quasispecies after 1-Year Treatment in HIV/HCV-Coinfected Patients According to the Pattern of Response to Highly Active Antiretroviral Therapy

2006 · Group for the HepaI.Co.N.A. and the I.Co.N.A. Study, F Ancarani, et al. · Antiviral Therapy · 11

PDF

Impact of Mutations Conferring Reduced Susceptibility to Lamivudine on the Response to Antiretroviral Therapy

2001 · Carlo Federico Perno, Alessandro Cozzi-Lepri, et al. · Antiviral Therapy · 10

PDF

Treatment of idiopathic thrombocytopenic purpura in HIV-positive patients with rhesus antibodies (anti-D).

1988 · E Rossi, A R Vimercati, et al. · PubMed · 7

[The Italian Fanconi Anemia Registry].

1999 · A Zatterale, R Calzone, et al. · PubMed · 3

The prognostic value to predict virological outcomes of 14 distinct systems used to interpret the results of genotypic HIV-1 drug resistance testing in untreated patients starting their first HAART

2004 · Andrea De Luca, Alessandro Cozzi Lepri, et al. · 2

Mycobacterial diseases and HIV infection.

1994 · G Pagano, G Carrega, et al. · PubMed · 2

Localisation gastrique de sarcome de kaposi au cours de sida

1986 · F. Munizzi, B. Gatteschi, et al. · Acta Endoscopica · 2

Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone

2009 · P Costa, F Bozzano, et al. · Clinical & Experimental Immunology · 1

PDF

115 Endocarditis Treatment and Antibiotic Hypersensitivity

2009 · M. Camera, F. Dodi, et al. · International Journal of Antimicrobial Agents

[LKM (Liver-Kidney-Microsome) antibodies and hepatitis C virus. Description of a clinical case].

1997 · M Durazzo, M A Biava, et al. · PubMed

[Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].

1995 · M Durazzo, C Costa, et al. · PubMed

[Imipenem-cilastatin in nosocomial infections in HIV+ patients].

1995 · G Pagano, T Repetto, et al. · PubMed

Beta-2 microglobulin (B2m) and neopterin (Ne) in serum and cerebrospinal fluid (CSF) of HIV-infected patients

1991 · A. Leonardi, G. Imberciadori, et al. · Journal of Neuroimmunology

Neurological complications in HIV infection. Personal experience.

1990 · A Alessandrini, A Canessa, et al. · PubMed

Works count: 42

Citation count: 259

H-index: 10

I10-index: 10